ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,310
Screening encounters
3,825
Diagnostic referrals
727
Outstanding pathways
279

Screening pathway

  1. Screening3,825Encounters
  2. Positive finding1,322Documented findings
  3. Referral727Diagnostic referrals
  4. Follow-up848Diagnostic visits
  5. Outcome448Resolved pathways

Stage totals use different units. Pending pathways: 279. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0447 · EXP-0447Synthetic · Site C

Full participant history through 2026-08-14, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA technically uninterpretable · Inadequate
  3. · Repeat plan · VIA · Inadequate result · Scheduled for 2025-10-15
  4. · Screening · VIA · Repeat · Inadequate result
  5. · Screening result · VIA · VIA positive · Adequate
  6. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-06-08
  7. · Diagnostic referral · EXP-0447-T-R
  8. · Contact attempt · Reached
  9. · Diagnostic booking · Initial booking
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · No high-grade lesion identified
  13. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-02-19
  14. · Follow-up disposition · Resolved · EXP-0447-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

3310 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0302 · Expanded synthetic participant 0302Site D — Community Engagement Programme
EXP-0304 · Expanded synthetic participant 0304Site B — Peri-Urban Access Programme
EXP-0307 · Expanded synthetic participant 0307Site A — Urban Referral Hub
EXP-0308 · Expanded synthetic participant 0308Site E — Resource-Constrained Navigation Programme
EXP-0311 · Expanded synthetic participant 0311Site E — Resource-Constrained Navigation Programme
EXP-0312 · Expanded synthetic participant 0312Site D — Community Engagement Programme
EXP-0315 · Expanded synthetic participant 0315Site B — Peri-Urban Access Programme
EXP-0316 · Expanded synthetic participant 0316Site D — Community Engagement Programme
EXP-0317 · Expanded synthetic participant 0317Site D — Community Engagement Programme
EXP-0318 · Expanded synthetic participant 0318Site B — Peri-Urban Access Programme
EXP-0319 · Expanded synthetic participant 0319Site C — Rural Outreach Programme
EXP-0322 · Expanded synthetic participant 0322Site B — Peri-Urban Access Programme
EXP-0323 · Expanded synthetic participant 0323Site B — Peri-Urban Access Programme
EXP-0324 · Expanded synthetic participant 0324Site A — Urban Referral Hub
EXP-0326 · Expanded synthetic participant 0326Site D — Community Engagement Programme
EXP-0327 · Expanded synthetic participant 0327Site E — Resource-Constrained Navigation Programme
EXP-0329 · Expanded synthetic participant 0329Site D — Community Engagement Programme
EXP-0330 · Expanded synthetic participant 0330Site B — Peri-Urban Access Programme
EXP-0331 · Expanded synthetic participant 0331Site A — Urban Referral Hub
EXP-0333 · Expanded synthetic participant 0333Site E — Resource-Constrained Navigation Programme
EXP-0335 · Expanded synthetic participant 0335Site A — Urban Referral Hub
EXP-0336 · Expanded synthetic participant 0336Site C — Rural Outreach Programme
EXP-0337 · Expanded synthetic participant 0337Site B — Peri-Urban Access Programme
EXP-0338 · Expanded synthetic participant 0338Site C — Rural Outreach Programme
EXP-0341 · Expanded synthetic participant 0341Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1512
HPV DNA
1766
Cytology
547

Navigation activity

Barrier documented
632
Contact attempt
1072
Navigation intervention
270
Diagnostic booking
897
Diagnostic visit
848

Documented barriers

Contact difficulty
210
Transport difficulty
198
Appointment coordination
224

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.